Woodland Park, NJ, United States of America

Edmund A Rossi

This inventor holds 77 USPTO granted patents and 20 published patent applications, plus 15 CIPO patents and 13 EPO patents, primarily in Immunotherapy Development (CPC class C07K). Top assignees: Ibc Pharmaceuticals, Inc., Immunomedics, Inc.. Active years: 2009-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Edmund A Rossi. Retrieved from https://idiyas.com/inventor/edmund-a-rossi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 77 (Patent Applications = 20)

% Patents Active = 87.0

CIPO Patents = 15

EPO Patents = 13 (Patent Applications = 11)

Average Co-Inventor Count = 3.9

ph-index = 26

Forward Citations = 1,870(Granted Patents)

Forward Citations (Not Self Cited) = 1,092(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Morris Plains, NJ (US) (2014)
Nutley, NJ (US) (2009 - 2017)
Woodland Park, NJ (US) (2010 - 2020)

Company Filing History:

52 out of 72

Ibc Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2009-2020

Loading Chart...

Areas of Expertise:

Immunotherapy

T-cell Redirecting Antibodies

Combination Therapy

Bispecific Antibodies

Antibody Compositions

Cytotoxic Activity

Trogocytosis

Cytokines

Stable Compositions

Pharmacokinetics

Immunotoxins

Mammalian Cell Lines

77 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10662252 - Disease therapy by inducing immune response to Trop-2 expressing cells (2020-05-26),

2. 10308688 - T-cell redirecting bispecific antibodies for treatment of disease (2019-06-04),

3. 10245321 - Combination therapy for inducing immune response to disease (2019-04-02),

4. 10239938 - T-cell redirecting bispecific antibodies for treatment of disease (2019-03-26),

5. 10183992 - T-cell redirecting bispecific antibodies for treatment of disease (2019-01-22),

6. 10131712 - Combination therapy with T-cell redirecting bispecific antibodies and checkpoint inhibitors (2018-11-20),

7. 10111954 - Combination therapy for inducing immune response to disease (2018-10-30),

8. 9963516 - Stable compositions of high-concentration allotype-selected antibodies for small-volume administration (2018-05-08),

9. 9963507 - Therapeutic use of anti-CD22 antibodies for inducing trogocytosis (2018-05-08),

10. 9931413 - Tetrameric cytokines with improved biological activity (2018-04-03),

11. 9879088 - Disease therapy by inducing immune response to Trop-2 expressing cells (2018-01-30),

12. 9872920 - PEGylation by the dock and lock (DNL) technique (2018-01-23),

13. 9745374 - Fusion proteins containing recombinant cytotoxic RNAses (2017-08-29),

14. 9737617 - Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases (2017-08-22),

15. 9683050 - Stable compositions of high-concentration allotype-selected antibodies for small-volume administration (2017-06-20),

Title: The Innovative Journey of Edmund A Rossi

Introduction: Edmund A Rossi, a talented inventor hailing from Woodland Park, NJ, has made significant contributions to the world of innovation through his groundbreaking ideas and inventions.

Latest Patents: Edmund A Rossi's latest patents include a revolutionary smart home device that enhances energy efficiency and a cutting-edge medical device aimed at improving patient care and outcomes.

Career Highlights: With a career spanning over two decades, Edmund A Rossi has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions to address them. His work has been recognized globally for its impact and ingenuity.

Collaborations: Throughout his career, Edmund A Rossi has collaborated with leading technology companies, research institutions, and universities to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: In conclusion, Edmund A Rossi's passion for innovation and dedication to creating solutions that make a difference have solidified his reputation as a respected inventor in the industry. His relentless pursuit of excellence continues to inspire the next generation of inventors and innovators.

Profile summary based on public USPTO records.